Article Impact Level: HIGH Data Quality: STRONG Summary of Metabolism https://doi.org/10.1016/j.metabol.2026.156570 Dr. Da Young Lee et al.
Points
- Researchers from Korea University evaluated one hundred twenty two type 2 diabetes patients receiving insulin therapy using continuous glucose monitors and wearable activity trackers over ten days.
- Comparative data showed that forty six point three percent of patients with stable circadian rhythms met glycemic targets compared to twenty percent with unstable biorhythms.
- Diurnal activity analysis revealed that afternoon physical activity between noon and six p m exhibited the strongest correlation with increased time in range and reduced glucose variability.
- Objective sleep tracking confirmed that sufficient sleep duration significantly reduced nocturnal hypoglycemic events and smoothed blood glucose fluctuations in insulin treated individuals.
- Authors concluded that circadian aligned behavioral interventions complement standard pharmacological care offering a novel lifestyle strategy to optimize glycemic control and prevent diabetic microvascular complications.
Summary
This study evaluated the relationship between circadian rhythm stability, daytime physical activity timing, and glycemic control in patients with type 2 diabetes receiving insulin therapy. Published in Metabolism by a collaborative research team from Korea University Ansan Hospital, Korea University Anam Hospital, and Sun Moon University, the cross-sectional exploratory study analyzed multi-modal continuous sensor data collected between 2021 and 2024. The research sought to determine whether circadian rhythmicity and time-of-day physical activity patterns independently correlate with time-in-range (TIR) and blood glucose variability beyond conventional clinical predictors like age, BMI, and baseline HbA1c.
The study enrolled 122 patients with type 2 diabetes undergoing insulin treatment, each monitored for 10 consecutive days using continuous glucose monitoring (CGM) devices paired with wearable activity trackers to collect synchronic metrics on glucose dynamics, sleep architecture, step counts, and heart rate variability. Quantitative analysis revealed that 46.3% of participants in the highest circadian rhythm stability tier achieved target glycemic management goals, compared to 20.0% in the lowest stability tier—representing a 2.3-fold increase in target attainment. Diurnal subgroup analysis divided 24-hour periods into early morning (00:00–06:00), morning (06:00–12:00), afternoon (12:00–18:00), and night (18:00–24:00). Afternoon physical activity demonstrated the strongest positive correlation with glycemic management, exhibiting increased time-in-range and reduced glucose variability. Additionally, adequate sleep duration strongly protected against nocturnal hypoglycemia and glycemic fluctuations.
The authors conclude that circadian rhythmicity and circadian-aligned afternoon physical activity are strongly associated with optimal glycemic control and reduced glucose variability in insulin-treated type 2 diabetes. These hypothesis-generating findings demonstrate that lifestyle timing plays an essential role alongside diet, exercise, and pharmacological management. The authors advocate for prospective clinical trials to evaluate whether circadian-aligned behavioral interventions can actively improve glycemic metrics and mitigate long-term microvascular complications, including diabetic kidney disease and retinopathy.
Link to the article: https://www.metabolismjournal.com/article/S0026-0495(26)00080-6/abstract
References
Lee, D. Y., Lee, J.-B., Jung, I., Park, S. Y., Yu, J. H., Seo, J. A., Lee, H.-J., & Kim, N. H. (2026). Association of daytime circadian-aligned activity with glycemic control in type 2 diabetes: Insights from continuous glucose monitoring and wearable data. Metabolism, 179, 156570. https://doi.org/10.1016/j.metabol.2026.156570
